Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at raps@raps.org if you need assistance.
The site navigation utilizes arrow, enter, escape, and space bar key commands. Left and right arrows move across top level links and expand / close menus in sub levels. Up and Down arrows will open main level menus and toggle through sub tier links. Enter and space open menus and escape closes them as well. Tab will move on to the next part of the site rather than go through menu items.
The regulatory function is vital in making safe and effective healthcare products available worldwide. Individuals who ensure regulatory compliance and prepare submissions, as well as those whose main job function is clinical affairs or quality assurance are all considered regulatory professionals.
Share your knowledge and expertise with your regulatory peers by submitting an in-depth, evidence-based article focusing on key areas and emerging issues in the global regulatory landscape.
One of our most valuable contributions to the profession is the Regulatory Code of Ethics. The Code of Ethics provides regulatory professionals with core values that hold them to the highest standards of professional conduct.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Like all professions, regulatory is based on a shared set of competencies. The Regulatory Competency Framework describes the essential elements of what is required of regulatory professionals at four major career and professional levels.
RAPS Euro Convergence brings regulatory peers from the EU and worldwide together in one forum to gain insights and exchange ideas on the region's most pressing issues. Register today to attend 10-12 May 2021.
Registration is now open for RAPS Convergence 2021! Gather with the regulatory community 12-15 September for four days of learning, engagement, and excitement.
With contributions from more than 30 authors from seven countries, the new edition incorporates a global overview of the field and is designed to help you get the most out of your regulatory intelligence endeavors.
Regipedia is an interactive resource created to benefit RAPS members with 24/7 access to more than 2,300 regulatory terms.
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
The RAPS store will be under maintenance Saturday, 17 April between 5 AM and 12 PM EST. Store functionality may be unavailable at times during this window. We apologize for any inconvenience caused during this time.
Posted 28 February 2013 | By Alexander Gaffney, RAC,
The Center for Devices and Radiological Health's (CDRH) ombudsman has released a report indicating that complaints made against the center and its employees have increased for a fourth straight year.
The data-driven annual report is an accounting of the total number of inquiries, complaints, disputes and other points of contact made to the ombudsman's office during each calendar year. The report is meant to identify any lingering issues that might be affecting the agency, as well as showcase general trends in complaints and inquiries.
The trend line for the past several years can be categorized in a word: up.
In 2012, the report notes that CDRH, the US Food and Drug Administration's (FDA) medical device regulatory center, received 493 inquiries and complaints through its ombudsman. That marks an average of 1.35 contacts for every calendar day of 2012, or 1.9 contacts for every weekday.
Of those 493, 45% (224) were actual complaints, while 44% (217) were inquiries, 8% (21) were disputes and 2% were "other" contacts.
The number of complaints has steadily risen over the last several years. In 2011, there were 202 complaints and 171 in 2010-an increase of 31% in two years, and 10.9% since 2011.
Inquiries, meanwhile, have remained nearly flat since 2010, when they totaled 206.
What's behind the spike? CDRH's report doesn't explain in words, but the data does show some trends. While industry accounts for a large number of contacts, it's actually not the source of the majority of the rise. In 2010 it registered 269 contacts, which rose to 285 in 2012.
Consumers, however, are contacting CDRH in greater and greater numbers, registering 124 complaints and inquiries in 2012-up 33% from 2010, when they registered just 93.
The overwhelming majority of all complaints registered in 2012 were sent to the Office of the Center Director-that is, Jeffery Shuren's office-which saw 330 points of contact, up 164% from the year prior and 440% from 2010.
The other notable trend seen in the data was the drop in complaints and inquiries sent to the Office of Device Evaluation (ODE), which saw a 36.8% decrease in contacts from 2011 to 2012.
The reasons for these complaints remained relatively constant, the ombudsman's data shows, with the exception of its "other" category, which seemed to account for the entirety of the increase from 2011 (47) to 2012 (86).
It was not clear from the data whether this increase was due to a spike in a single issue of interest generating concern, or if a rising number of complaints are just more difficult to categorize using the ombudsman 10 pre-defined categories. A similar increase was seen between 2010 and 2011, from 7 to 47.
Tags: Ombudsman, Report
Regulatory Focus newsletters
All the biggest regulatory news and happenings.